Corient Private Wealth
TMO icon

Corient Private Wealth’s Thermo Fisher Scientific TMO Stock Holding History

Corient Private Wealth’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$355M Sell
707,412
-124,657
-15% -$59.8M 0.49% 36
2026
Q1 		$417M Buy
832,069
+33,843
+4% +$18.4M 0.6% 28
2025
Q4 		$463M Buy
798,226
+66,029
+9% +$37.3M 0.63% 25
2025
Q3 		$355M Sell
732,197
-143,246
-16% -$66.7M 0.56% 27
2025
Q2 		$355M Sell
875,443
-51,515
-6% -$21.5M 0.47% 33
2025
Q1 		$461M Buy
926,958
+31,031
+3% +$16.8M 0.75% 22
2024
Q4 		$465M Sell
895,927
-54,001
-6% -$29.7M 0.77% 19
2024
Q3 		$588M Buy
949,928
+23,467
+3% +$13.9M 0.92% 19
2024
Q2 		$512M Sell
926,461
-13,331
-1% -$7.64M 0.89% 18
2024
Q1 		$546M Sell
939,792
-3,762
-0.4% -$2.11M 0.97% 13
2023
Q4 		$501M Buy
943,554
+124,673
+15% +$60.3M 0.92% 16
2023
Q3 		$414M Sell
818,881
-9,704
-1% -$5.17M 0.95% 17
2023
Q2 		$432M Buy
828,585
+20,751
+3% +$11.2M 1% 15
2023
Q1 		$466M Buy
807,834
+195,489
+32% +$110M 1.25% 6
2022
Q4 		$337M Buy
+612,345
New +$324M 1.22% 8

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Corient Private Wealth's TMO Position: Q2 2026 in Review

Corient Private Wealth reduced its Thermo Fisher Scientific (TMO) stake by 15% in Q2 2026, selling an estimated $59.8M and leaving 707,412 shares worth $355M. The position accounts for 0.49% of the portfolio, ranked #36.

Corient Private Wealth first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $588M in Q3 2024. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Corient Private Wealth held 707,412 shares of Thermo Fisher Scientific worth $355M as of Q2 2026.
  • Corient Private Wealth sold 124,657 Thermo Fisher Scientific shares in Q2 2026, an estimated $59.8M.
  • Thermo Fisher Scientific made up 0.49% of Corient Private Wealth's portfolio in Q2 2026, its #36 holding.
  • Corient Private Wealth first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's Thermo Fisher Scientific position peaked at $588M in Q3 2024.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.